Amgen to expand Ohio biotech manufacturing plant
By Deena Beasley
(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump administration threats of potential import tariffs.
Amgen, based in Thousand Oaks, California, said the plans bring its total investment in central Ohio to more than $1.4 billion, creating 750 jobs.
Other drugmakers committing recently to U.S. manufacturing expansions include Eli Lilly, Novartis, Roche, and Johnson & Johnson.
Pharmaceutical Research and Manufacturers of America, the industry's trade group, has said it can take five to 10 years and $2 billion to launch a new U.S. production facility in part because of regulatory requirements. A study commissioned by the lobbying group found that tariffs could lead to higher drug prices.
U.S. President Donald Trump's administration has opened a national security investigation into pharmaceuticals in a bid to demonstrate why the U.S. needs tariffs to boost domestic manufacturing. Rates and timing remain uncertain, but the industry has been lobbying for phased-in tariffs.
Amgen said that since passage of the Tax Cuts and Jobs Act of 2017 it has invested almost $5 billion in U.S. capital expenditures, generating additional downstream output to the U.S. economy of around $12 billion.
The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing facilities in Massachusetts, Rhode Island, California and Puerto Rico.
Outside of the United States, Amgen's manufacturing operations are in Ireland, the Netherlands and Singapore.
(Reporting By Deena Beasley; Editing by Hugh Lawson)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
India's Paytm slumps after government says reports of UPI transaction fees false
(Reuters) -Shares of digital payments firm Paytm slumped as much as 10% on Thursday after India's finance ministry said that reports about the introduction of fees on the popular unified payments interface (UPI) transactions were false and baseless. The shares posted their sharpest intraday fall since February 2024, before coming off lows to trade down 8%. India's benchmark Nifty 50 was trading 0.2% lower. In India, merchants pay fees to banks or payment service providers, such as Paytm, for transactions. There is no fees on UPI payments. The delay or non-introduction of the fees is "sentiment negative for Paytm", brokerage UBS said, adding that the firm's adjusted core profits could decline more than 10% in fiscal years 2026 and 2027 if increased incentives are absent.
Yahoo
27 minutes ago
- Yahoo
Bad actors in LA protests a 'good thing' for Trump's immigration agenda: Chuck Rocha
Protests in Los Angeles and other cities continue as citizens protest ICE raids taking place in their communities. Democratic strategist Chuck Rocha encourages Americans to protest if they have disagreements with the government but cautions against bad actors who cause destruction and violence, saying, "Those are the imagery Donald Trump wants to see … because it's a good thing for him." Rocha talks about how President Trump campaigned on immigration, which he says is a key reason Trump was reelected. Rocha believes Democrats have a hard time sticking to core values and need to return to those if they want to win elections. #DonaldTrump #LosAngeles #ICEprotests
Axios
28 minutes ago
- Axios
Pam Bondi: LA protesters "very different" to Jan. 6 rioters Trump pardoned
The Trump administration is "not scared to go further" in its response to Los Angeles ' ongoing fiery protests against Immigration and Customs Enforcement (ICE) raids, Attorney General Pam Bondi said Wednesday. Why it matters: President Trump has referred to protesters as "insurrectionists" and has already taken the rare steps of federalizing California's National Guard and deploying the Marines to LA, prompting reporters to ask Bondi whether he'll next use emergency powers under the Insurrection Act. California's Democratic leaders have expressed strong opposition to the federal response, and Trump and Gov. Gavin Newsom (D) have traded insults as they blamed each other for the unrest. What they're saying: "Right now, in California, what we're doing is working," Bondi said, after being asked about whether Trump would invoke the 1807 law that allows presidents to deploy U.S. troops to quell domestic unrest. "By bringing in the National Guard, by bringing in the Marines, right now, to back them up, to protect our federal buildings, to protect highways, to protect the citizens," she said during her briefing with reporters. "So, right now, in California, we're at a good point. We're not scared to go further. We're not frightened to do something else if we need to." Bondi expressed hope that the federal action and the downtown night-time curfew that LA Mayor Karen Bass imposed on Tuesday to address looting and vandalism would bring the situation under control. Of note: Newsom in a Tuesday night address said that Trump is "not opposed to lawlessness and violence, as long as it serves HIM," adding: "What more evidence do we need than Jan. 6th?" A reporter asked Bondi whether there was a double standard in the administration defending law enforcement during the current protests when Trump pardoned most of the roughly 1,500 Jan. 6 rioters during his first day back in office. "Well, this is very different," Bondi said. "These are people out there hurting people in California right now. This is ongoing." State of play: There have now been six days of ICE protests in LA, and they've triggered similar demonstrations nationwide.
